Harrow

Harrow Quick Ratio

The Quick Ratio (Acid Test) of Harrow (HROW) as of Oct 10, 2026 is 1.27. In the previous year, Quick Ratio (Acid Test) was 1.24 — a change of 2.35% (higher).

Quick Ratio

1.27

YoY

2.35%

Last updated:

Quick Ratio (Acid Test) of Harrow is 2025 1.27 . Quick Ratio (Acid Test) of Harrow was 2024 1.24 . It decreases by 2.35% higher compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Quick Ratio (Acid Test) of Harrow is 1.27 in 2025.

Quick Ratio (Acid Test) of Harrow changed from 1.24 to 1.27, representing a 2.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Harrow since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Harrow with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Harrow

All Key Metrics — Harrow